Enrollment of African Americans Onto Clinical Treatment Trials: Study Design Barriers

Author:

Adams-Campbell Lucile L.1,Ahaghotu Chiledum1,Gaskins Melvin1,Dawkins Fitzroy W.1,Smoot Duane1,Polk Octavius D.1,Gooding Robert1,DeWitty Robert L.1

Affiliation:

1. From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC

Abstract

Purpose African Americans have the highest cancer mortality rates and poorest survival and are more often uninsured and underinsured compared with other ethnic groups. Minority participation in clinical trials has traditionally been low, with reports ranging from 3% to 20%. The present study systematically assesses 235 consecutively diagnosed African American cancer patients regarding recruitment onto cancer treatment clinical trials at Howard University Cancer Center between January 1, 2001, and December 31, 2002. Our intent is to determine the rate-limiting factors associated with enrolling African Americans onto clinical trials at a historically black medical institution. Patients and Methods Two hundred thirty-five consecutively diagnosed African American cancer patients were assessed for participation in clinical trials at Howard University Hospital and Cancer Center. The study population comprised 165 women and 70 men. Results The overall eligibility rate was 8.5% (20 of 235 patients); however, among those eligible, the enrollment rate (ie, enrollment among the eligible population) was 60.0% (12 of 20 patients). Comorbidities rendered 17.1% of the patient population ineligible for the trials. Advanced disease stage, associated with poor performance status, premature death, and short life expectancy, made an additional 10% of the patient population ineligible. Respiratory failure, HIV positivity, and anemia accounted for 37.8% of the comorbidities in this population. Cardiovascular diseases and renal insufficiency represented 16.2% of the comorbidities. Conclusion It was evident that study design exclusion and inclusion criteria rendered the majority of the study population ineligible. Among African Americans, comorbidity is a major issue that warrants considerable attention.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Reference20 articles.

1. Haynes MA, Smedley BC The unequal burden of Cancer: Committee on Cancer Research Among Minorities and the Medically Underserved . Washington, DC, Institute of Medicine, National Academy Press, 1999

2. Cancer Facts and Figures for African-Americans 2000–2001 . Atlanta, GA, American Cancer Society, pp 2,2000–7

3. Ries LAG, Eisner MP, Kosary CL, et al (eds): SEER Cancer Statistics Review, 1979–1997 . Bethesda, MD, National Cancer Institute, 2000

4. Effects on Mortality of Getting the Basic Health Examination Under the Health Services for the Elderly Act and Modification of the Effects by Health Status Among Elderly Persons in a Rural Community.

5. Recruiting Minorities Into Clinical Trials Toward a Participant-Friendly System

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3